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Editorial on the Research Topic
The Immunomodulatory Properties of Extracellular Vesicles From Pathogens, Immune Cells,
and Non-immune Cells
INTRODUCTION
Intercellular communication is key for immune regulation and extracellular vesicles (EVs) are
emerging as important mediators of this process. EVs like exosomes, microvesicles, and apoptotic
bodies are membrane-bound vesicles that can be released by both immune and non-immune
cells. Although different types of EVs vary greatly in their size (∼30 nm to 5µm in diameter)
and mechanism of formation, it is now well-established that the cellular constituents in/on EVs
(e.g., antigens, cytokines, membrane proteins, and microRNAs) can regulate a variety of immune
responses. Besides mammalian cells, bacteria, fungi, and parasites can also release membrane
vesicles to modulate host immune responses. In this research topic, a collection of primary research
and review papers explored the immunoregulatory properties of EVs released from immune cells,
tumor cells, apoptotic cells as well as pathogens.
IMMUNOREGULATORY PROPERTIES OF EVS RELEASED FROM
GRANULOCYTES AND MACROPHAGES
EVs can be released from a variety of cell types, in particular by immune cells to regulate immune
responses (1). In this research topic, small and large EVs (<220 nm and >220 nm, respectively)
generated from granulocytes were described by Danesh et al. to exhibit immunostimulatory
properties on monocytic cells. Interestingly, the authors also observed a positive association
between the levels of CD66b+ granulocyte-derived EVs with mortality in intensive care unit
patients. In another study in this research topic, Alvarez-Jimenez et al. described the ability of
EVs generated from Mycobacterium tuberculosis-infected neutrophils (∼100–700 nm) to promote
the release of proinflammatory cytokines from macrophages and removal of intracellular M.
tuberculosis via an autophagy-dependent mechanism. Furthermore, Singhto et al. examined the
role of macrophage-derived EVs (∼50–80 nm) in the context of kidney stone pathogenesis. The
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authors described the proteomic profile of macrophage-derived
EVs following calcium oxalate monohydrate crystals (a type
of crystal that is more pathogenic in kidney stone disease)
treatment, and how these EVs could modulate a variety of
immune cell functions in vitro. Collectively, these studies
highlight the immunomodulatory properties of EVs generated
from immune cells.
IMMUNOREGULATORY PROPERTIES OF
EVS RELEASED FROM TUMOUR AND
APOPTOTIC CELLS
Tumor cells can play a key role in establishing a
microenvironment that favors their growth, and a variety
of soluble factors released from tumor cells including VEGF
and IL-10 have been shown to facilitate this process (2).
Similarly, tumor cell-derived exosomes and microvesicles
have also been reported to contribute to the establishment
of tumor microenvironment (3, 4). In this research topic,
Dörsam et al. reported the ability of EVs (∼130 nm) generated
from Hodgkin lymphoma to promote recipient fibroblasts to
exhibit a cancer-associated fibroblast phenotype, resulting in
the release of pro-inflammatory cytokines, growth factors and
pro-angiogenic factors that could facilitate a tumor supportive
environment. In another research article, Dionisi et al. explored
a different concept and demonstrated the ability of tumor
(Burkitt’s lymphoma)-derived microvesicles (3 predominant EV
populations of ∼105, 175, and 285 nm) carrying tumor antigens
to enhance cross-processing ability of clinical grade dendritic
cells and facilitate activation of CD8+ T cells. These findings
suggest the potential use of tumor cell-derived microvesicles
to promote the efficacy of dendritic cell-based vaccines for
anti-tumor immunotherapy.
In addition to EVs released from healthy/viable tumor cells,
two reviews by Gregory and Dransfield andMuhsin-Sharafaldine
and McLellan discussed the recent literature on the ability EVs
released from apoptotic tumor cells to modulate tumor growth
and anti-tumor immunity. Firstly, Gregory and Dransfield
described the heterogeneity of apoptotic cell-derived EVs in
terms of size and content, as well as their mechanism of
formation. The authors also discussed how EVs could facilitate
intercellular communication in the tumor microenvironment
and regulate tumor growth, metastasis, drug resistance, and anti-
tumor immunity. However, the importance of EVs generated
from apoptotic cells (ApoEVs), in particular from dying tumor
cells, in modulating the tumor microenvironment remains
to be fully defined. Muhsin-Sharafaldine and McLellan also
discussed how ApoEVs generated from tumor cells could
exhibit immunosuppressive or immunostimulatory properties
depending on the experimental context. In particular, how
CD169+ macrophages in the lymph node could play a key
role in interacting with tumor cell-derived ApoEVs and
regulate anti-tumor immunity, as well as how the exposure
of phosphatidylserine on tumor cell-derived ApoEVs (e.g.,
generated after chemo-/radio-therapy) could promote tumor
growth through activation of the extrinsic coagulation cascade.
It should be noted that in additional to tumor cell-derived
ApoEVs, ApoEVs released from a range of untransformed
cells during apoptosis could also exhibit immunoregulatory
properties. Another review by Caruso & Poon discussed how
ApoEVs generated from a range of cell types could modulate
immune responses by regulating the efficient clearance of
apoptotic cells, antigen presentation, as well as trafficking of
cytokines, damage-associated molecular patterns and pathogens.
Caruso and Poon also highlighted the variation in nomenclature
and isolation/characterizationmethods used in a range of ApoEV
studies.
IMMUNOREGULATORY PROPERTIES OF
EVS RELEASED FROM PATHOGENS
In additional to the importance of EVs in mediating intercellular
communication in higher organisms, it is also well-established
that a variety of pathogens can release membrane vesicles to
modulate host immunity (5), with three research articles in this
research topic exploring this area of research. First, Turner et
al. examined the mechanism underpinning the entry of Gram-
negative bacterial derived outer membrane vesicles (OMVs) into
host cells. The authors described the size of OMV being a key
determining factor for OMV cargo composition and their host
cell entry, with smaller OMVs (20–100 nm) and larger OMVs
(90–450 nm) entering host epithelial cells via caveolin-mediated
endocytosis and macropinocytosis/endocytosis, respectively.
Second, Eichenberger et al. performed proteomic and RNA-seq
analysis on parasite (Nippostrongylus brasiliensis)-derived EVs
(60–160 nm), as well as demonstrated the ability of parasite-
derived EVs to suppress inflammation in a murine model of
colitis. Lastly, Ofir-Birin et al. described the use of imaging
flow cytometry to monitor malaria parasites (Plasmodium
falciparum)-derived EVs, their uptake into host monocytes, as
well as the subsequent translocation of phosphorylated IRF3 into
the nucleus in monocytes.
AFTERWORD
The field of EVs is a rapidly growing area of research, with
the identification of new types of EVs, expansion on the cell
types or organisms that could release EVs and their functions, as
well as the development of novel approaches to study EVs. This
research topic has covered a number of cutting-edge discoveries
in this field. Lastly, we would like to thank all the authors for
their contribution to this research topic and the referees for their
prompt and in-depth reviews.
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